Amarin Corp Plc (AMRN)

[ziploc_1]

Amarin needs to perform a short term lab study of EPA levels in patients taking one 2 gram dose of MD-2119 a day vs. those taking two 2 gram doses of MD-2119 a day...and compare the EPA levels in each group...with those EPA levels known from previous studies to have been effective in reducing CVD.

It may turn out not to be necessary for Amarin to produce a four gram capsule of MD-2119...and just seek FDA approval for the two gram version.

If necessary, MD-2119 can be used morning and night...It is still better than taking four 1 gram capsules a day....especially since many patients taking Vascepa have multiple meds to take each day.